Hormone replacement therapy and ovarian cancer risk: A meta-analysis
- 1 March 2008
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 108 (3) , 641-651
- https://doi.org/10.1016/j.ygyno.2007.12.003
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- A prospective study of postmenopausal hormone use and ovarian cancer riskBritish Journal of Cancer, 2006
- Menopausal Hormone Therapy and Ovarian Cancer Risk in the National Institutes of Health–AARP Diet and Health Study CohortJNCI Journal of the National Cancer Institute, 2006
- Menopausal hormones and risk of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2005
- Hormone replacement therapy and invasive and borderline epithelial ovarian cancer riskCancer Detection Prevention, 2005
- Hormone replacement therapy and incidence of hormone‐dependent cancers in the Norwegian Women and Cancer studyInternational Journal of Cancer, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Ovarian cancer patients and hormone replacement therapy: a systematic reviewGynecologic Oncology, 2004
- Estrogen Replacement Therapy and Ovarian CancerEpidemiology, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- The epidemiology of ovarian cancer in Greece: A case-control studyEuropean Journal of Cancer and Clinical Oncology, 1984